CD49b (ITGA2) human monoclonal antibody, clone F2H11
Applications | ELISA, FC, IF |
Reactivities | Human |
Conjugation | Unconjugated |
CD49b (ITGA2) human monoclonal antibody, clone F2H11
Applications | ELISA, FC, IF |
Reactivities | Human |
Conjugation | Unconjugated |
CD49b (ITGA2) human monoclonal antibody, clone B4F12
Applications | ELISA, FC, IF |
Reactivities | Human |
Conjugation | Unconjugated |
CD49b (ITGA2) human monoclonal antibody, clone F2H11
Applications | FC, IF |
Reactivities | Human |
Conjugation | Alexa Fluor 488 |
CD49b (ITGA2) human monoclonal antibody, clone F2H11
Applications | FC, IF |
Reactivities | Human |
Conjugation | Alexa Fluor 546 |
CD49b (ITGA2) human monoclonal antibody, clone F2H11
Applications | FC, IF |
Reactivities | Human |
Conjugation | Alexa Fluor 647 |
CD49b (ITGA2) human monoclonal antibody, clone F2H11
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Biotin |
CD49b (ITGA2) human monoclonal antibody, clone B4F12
Applications | FC, IF |
Reactivities | Human |
Conjugation | Alexa Fluor 488 |
CD49b (ITGA2) human monoclonal antibody, clone B4F12
Applications | FC, IF |
Reactivities | Human |
Conjugation | Alexa Fluor 647 |
CD49b (ITGA2) human monoclonal antibody, clone B4F12
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Biotin |
Carrier-free (BSA/glycerol-free) A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
Carrier-free (BSA/glycerol-free) A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
CD38 monoclonal antibody (daratumumab biosimilar)
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
CD70 monoclonal antibody (vorsetuzumab biosimilar)
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
SARS-CoV-2 monoclonal antibody (CB6 biosimilar)
Applications | ELISA, FC |
Reactivities | SARS-CoV-2 |
Conjugation | Unconjugated |
SARS-CoV monoclonal antibody (CR3022 biosimilar)
Applications | ELISA, FC |
Reactivities | SARS-CoV-2 |
Conjugation | Unconjugated |
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
Applications | ELISA, FC, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD52 (Clone Campath-1H)
Applications | ELISA, FC, IHC, WB |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD20 (Clone 10F381 (rituximab))
Applications | FC |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Conjugation | Unconjugated |
Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Conjugation | His Tag |
Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Conjugation | Unconjugated |
Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Conjugation | Unconjugated |
Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Conjugation | Unconjugated |
Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-TRP-1, gp75 (Clone TA99)
Applications | ELISA, FC, IF, IHC, IP, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
USD 523.00
2 Weeks
Recombinant Anti-IL-2R (Clone Daclizumab)
Applications | FC |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
USD 523.00
2 Weeks
Recombinant Anti-IL-2R alpha (CD25) (Clone Basiliximab)
Applications | FC, IF, IHC, WB |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-EGFR (Clone C225 (Cetuximab))
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-carcinoembryonic antigen (CEA) (Clone Arcitumomab)
Applications | FC, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD41 (Clone 7E3 (Abciximab))
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD33 (Clone hP67.6 (Gemtuzumab))
Applications | FC, IF |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-Human Ephrin Type A receptor 2 (Clone 1C1)
Applications | ELISA, FC, IF, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD40L (Clone hu5c8 (Ruplizumab))
Applications | FC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
USD 523.00
2 Weeks
Recombinant Anti-alpha 5 beta 1 Integrin (Clone M200 (Volociximab))
Applications | ELISA, FC, IF, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD4 (Clone CE9.1 (Clenoliximab))
Applications | ELISA, FC, IHC |
Reactivities | Chimpanzee, Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-alpha-gal epitope (Clone m86)
Applications | ELISA, FC |
Conjugation | Unconjugated |
Modifications | This chimeric human antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-EGFR (Clone Matuzumab)
Applications | ELISA, FC, IF, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD11a (Clone hu1124 (Efalizumab))
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-OX40L (Clone R4930 (Oxelumab))
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-VEGF (Clone Bevacizumab)
Applications | ELISA, FC, IP, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
USD 523.00
2 Weeks
Recombinant Anti-Integrin alpha 4 (Clone Natalizumab)
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-EGFR domain III (Clone h-R3 (Nimotuzumab))
Applications | FC, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD22 (Clone hL22 (Epratuzumab))
Applications | Bl, FC, IP |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Recombinant Anti-CD64 (Clone H22)
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric human antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD80 (Clone IDEC-114 (Galiximab))
Applications | ELISA, FC, IHC, IP, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD40 (Clone 5D12)
Applications | ELISA, FC, IHC, IP |
Reactivities | Human, Monkey, Cynomolgus |
Conjugation | Unconjugated |
Recombinant Anti-Fas (Clone R-125224)
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-Rhesus D antigen (Clone D7C2)
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
USD 523.00
2 Weeks
Recombinant Anti-EGFR (Clone 2F8 (Zalutumumab; HuMax-EGFR))
Applications | ELISA, FC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-BRD4 (Clone RAB-C131)
Applications | ChIP, ELISA, FC, IF |
Reactivities | Human |
Conjugation | His Tag |